Stroke Diagnostic and Therapeutic Market (By Type: Diagnostics (Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT scan), Electrocardiography, Carotid Ultrasound, Cerebral Angiography, and Others) and Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant); By Application: Haemorrhagic Stroke and Ischemic Stroke)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global stroke diagnostic and therapeutic market size was exhibited at USD 35.35 billion in 2022 and is projected to hit around USD 77.02 billion by 2032, growing at a CAGR of 3.5% during the forecast period 2023 to 2032.

stroke diagnostic and therapeutic market size

Key Pointers:

  • The Diagnostics Segment Is Predictable To Lead the Type Segment of Stroke Diagnostic and Therapeutic Market Revenue
  • Ischemic stroke Segment Is Likely to Take over the Application Segment of Stroke Diagnostic And Therapeutic Market Revenue
  • The North American region is anticipated to considerably contribute to market growth from 2023 to 2032.
  • The Asia Pacific region will grow at the fastest CAGR from 2023 to 2032.

Stroke diagnostic and therapeutic Market Report Scope

Report Coverage Details
Market Size in 2023 USD 38.21 Billion
Market Size by 2032 USD 77.02 Billion
Growth Rate from 2023 to 2032 CAGR of 3.5%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Type, Application
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Growing ongoing research & development in the healthcare sector technologies for the stroke can create lucrative growth opportunities for the key players operating in the global market. In the developed countries such as U.S and Canada the healthcare treatment, service costs are relatively high owing to availability of advanced healthcare infrastructure. Due to the ongoing healthcare technology advancements highly sophisticated tools and apps are used every day, around the globe. Scientific and technical developments give rise to more powerful methods for disease prevention and recovery. Despite various technical advancements benefiting different medical fields, it's no wonder that such innovations often create waves in stroke management. In addition to defining and recognizing the symptoms of this disease, both IT and mobile health apps provide valuable resources to resolve the issues that occur in this field. Technology also benefits healthcare providers, and without complex procedures, patients can monitor their heart health. Advanced technology also assists with prevention, diagnosis, and recovery. Further, growth in emerging economies is another factor to creating growth opportunity for the key players in the global market.

The study report delivers prospects and trends of stroke diagnostic and therapeutic products across different geographical regions counting Europe, North America, Latin America, Asia-Pacific, Middle East, and Africa. However, geographically, the stroke diagnostic and therapeutic market is dominated by North America due to growing stroke patient’s pool in the countries U.S. and Canada, availability of advanced healthcare infrastructure, presence of key market players, and government initiatives that improve access to advanced power instruments the treatment of stroke in the North America. Europe constitutes a share more than 25% of the global in 2020. Presence of key operating players in the countries of the region is expected to help the development of the Europe market in the coming years of the forecast period ranging. Asia Pacific stroke diagnostics and therapeutics market is anticipated to grow at a CAGR of 8.4% over the forecast period. Increasing health awareness among the individuals in the emerging economies is expected to help in driving the growth of the global market in Asia Pacific region.

Some of the prominent players in the Stroke diagnostic and therapeutic Market include:

  • Neural Analytics
  • Cordis Corporation
  • Cerebrotech Medical Systems, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc.
  • Boston Scientific Corporation
  • GE Healthcare
  • Medfield Diagnostics
  • Samsung Neurologica
  • NIRX
  • Gowerlabs
  • Siemens AG
  • Genentech Inc.
  • Merck & Co., Inc.
  • Hyperfine MRI
  • Stryker Corporation
  • Abbott Laboratories

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global stroke diagnostic and therapeutic market.

By Type

  • Diagnostics
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography Scan (CT scan)
    • Electrocardiography
    • Carotid Ultrasound
    • Cerebral Angiography
    • Others
  • Therapeutics
    • Tissue Plasminogen Activator
    • Antiplatelet
    • Antihypertensive
    • Anticoagulant

By Application

  • Haemorrhagic Stroke
  • Ischemic Stroke

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global stroke diagnostic and therapeutic market size was exhibited at USD 35.35 billion in 2022 and is projected to hit around USD 77.02 billion by 2032

The global stroke diagnostic and therapeutic market is growing at a compound annual growth rate (CAGR) of 3.5% from 2023 to 2032.

The key companies functioning in the worldwide stroke diagnostic and therapeutic are Neural Analytics, Cordis Corporation, Cerebrotech Medical Systems, Inc. Koninklijke Philips N.V. Medtronic plc. Boston Scientific Corporation, GE Healthcare, Medfield Diagnostics, Samsung Neurologica, NIRX, Gowerlabs, Siemens AG, Genentech Inc. Merck & Co., Inc. Hyperfine MRI, Stryker Corporation, Abbott Laboratories among others.

Increasing number of patients at risk of increasing stroke across the globe is major factor driving growth of the global stroke diagnostics and therapeutic market. Increasing prevalence of high blood pressure among the population across the globe which is a key risk factor fuelling patients developing stroke at risk.

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Stroke Diagnostic And Therapeutic Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Stroke Diagnostic And Therapeutic Market

5.1. Covid-19: stroke diagnostic and therapeutic Industry Impact
5.2. stroke diagnostic and therapeutic Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and stroke diagnostic and therapeutic Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for stroke diagnostic and Therapeutic Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Stroke Diagnostic And Therapeutic Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1.1. Increasing number of patients at risk of developing stroke
6.1.1.1.2. Increasing patient awareness
6.1.1.1.3. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost of treatment and unfavorable reimbursement scenario
6.1.3. Market Opportunities
6.1.3.1. Growing ongoing research & development in the healthcare sector technologies and emerging markets

Chapter 7. Global Stroke Diagnostic And Therapeutic Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. stroke diagnostic and Therapeutic Market Revenue by Market Players (2018 - 2023)
7.1.1.2. stroke diagnostic and Therapeutic Market Revenue Market Share by Market Players (2018 - 2023)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Stroke Diagnostic And Therapeutic Market, By Type

8.1. stroke diagnostic and Therapeutic Market, by Type, 2018-2032
8.1.1. Diagnostic
8.1.1.1. Market Revenue and Forecast (2018-2032)
8.1.2. Therapeutics
8.1.2.1. Market Revenue and Forecast (2018-2032)

Chapter 9. Global Stroke Diagnostic And Therapeutic Market, By Application

9.1. stroke diagnostic and therapeutic Market, by Application, 2018-2032
9.1.1. Haemorrhagic Stroke
9.1.1.1. Market Revenue and Forecast (2018-2032)
9.1.2. Ischemic Stroke
9.1.2.1. Market Revenue and Forecast (2018-2032)

Chapter 10. Global Stroke Diagnostic And Therapeutic Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Type (2018-2032)
10.1.2. Market Revenue Forecast by Application(2018-2032)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2018-2032)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2018-2032)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2018-2032)
10.2.2. Market Revenue Forecast by Application (2018-2032)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2018-2032)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2018-2032)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2018-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2018-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2018-2032)
10.3.2. Market Revenue Forecast by Application (2018-2032)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2018-2032)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2018-2032)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2018-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2018-2032)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2018-2032)
10.4.2. Market Revenue Forecast by Application (2018-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2018-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2018-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2018-2032)
10.5.2. Market Revenue Forecast by Application (2018-2032)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2018-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2018-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2018-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2018-2032)

Chapter 11. Company Profiles

11.1. Boston Scientific Corporation
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2018-2023)
11.1.4. Recent Developments and Strategies
11.2. Medtronic plc
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2018-2023)
11.2.4. Recent Developments and Strategies
11.3. Cerebrotech Medical Systems, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2018-2023)
11.3.4. Recent Developments and Strategies
11.4. Cordis Corporation
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2018-2023)
11.4.4. Recent Developments and Strategies
11.5. Neural Analytics
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2018-2023)
11.5.4. Recent Developments and Strategies
11.6. Koninklijke Philips N.V.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2018-2023)
11.6.4. Recent Developments and Strategies
11.7. Medfield Diagnostics
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2018-2023)
11.7.4. Recent Developments and Strategies
11.8. GE Healthcare
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2018-2023)
11.8.4. Recent Developments and Strategies
11.9. Samsung Neurologica
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2018-2023)
11.9.4. Recent Developments and Strategies
11.10. Siemens AG
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2018-2023)
11.10.4. Recent Developments and Strategies
11.11. NIRX
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Product Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin (2018-2023)
11.11.4. Recent Developments and Strategies
11.12. Gowerlabs
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Product Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin (2018-2023)
11.12.4. Recent Developments and Strategies
11.13. Stryker Corporation
11.13.1. Company Overview, Business Information, Regional Presence
11.13.2. Product Portfolio Analysis
11.13.2.1. Product Details, Specification, Application
11.13.3. Revenue, Price, and Gross Margin (2018-2023)
11.13.4. Recent Developments and Strategies
11.14. Genentech Inc.
11.14.1. Company Overview, Business Information, Regional Presence
11.14.2. Product Portfolio Analysis
11.14.2.1. Product Details, Specification, Application
11.14.3. Revenue, Price, and Gross Margin (2018-2023)
11.14.4. Recent Developments and Strategies
11.15. Merck & Co., Inc.
11.15.1. Company Overview, Business Information, Regional Presence
11.15.2. Product Portfolio Analysis
11.15.2.1. Product Details, Specification, Application
11.15.3. Revenue, Price, and Gross Margin (2018-2023)
11.15.4. Recent Developments and Strategies
11.16. Hyperfine MRI
11.16.1. Company Overview, Business Information, Regional Presence
11.16.2. Product Portfolio Analysis
11.16.2.1. Product Details, Specification, Application
11.16.3. Revenue, Price, and Gross Margin (2018-2023)
11.16.4. Recent Developments and Strategies
11.17. Abbott Laboratories
11.17.1. Company Overview, Business Information, Regional Presence
11.17.2. Product Portfolio Analysis
11.17.2.1. Product Details, Specification, Application
11.17.3. Revenue, Price, and Gross Margin (2018-2023)
11.17.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert